Formulation strategies in immunotherapeutic pharmaceutical products

doi:10.5306/wjco.v11.i5.275

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8736)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

566

WORD

179

HTML

4929

Figures (1-1)

340

Tables (1-2)

779

Sum=6793

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

775

Download

1168

Sum=1943

May 24, 2020 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. May 24, 2020; 11(5): 275-282
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.275

Full Size Figure Download Figure

Figure 1 Cartoon of antibody formulations and excipients. Heavy chain (purple) and light chain (brown) constant regions; heavy (purple) and light (brown) antigen-binding variable regions. Excipients are depicted as gray rectangles which associate with Abs in noncovalent fashion.

Citation: Zhang Y, Williams III RO, Tucker HO. Formulation strategies in immunotherapeutic pharmaceutical products. World J Clin Oncol 2020; 11(5): 275-282
URL: https://www.wjgnet.com/2218-4333/full/v11/i5/275.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i5.275